KARI EWALT: Open Payments
NPI 1962559682 · ROCHESTER HILLS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$12,711 in 233 payments from 18 companies in 2025. Trend: 2023 $6,901 · 2024 $10,635 · 2025 $12,711
Speaker / faculty: $5,650Food & beverage: $4,645Travel & lodging: $1,331Consulting: $960Education: $125
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 82 | $7,659 |
| UCB, Inc. | 19 | $2,193 |
| ABBVIE INC. | 43 | $855 |
| Janssen Biotech, Inc. | 18 | $599 |
| GENZYME CORPORATION | 13 | $517 |
| Novartis Pharmaceuticals Corporation | 12 | $289 |
| E.R. Squibb & Sons, L.L.C. | 28 | $221 |
| GlaxoSmithKline, LLC. | 3 | $60 |
| AstraZeneca Pharmaceuticals LP | 2 | $49 |
| Genentech USA, Inc. | 2 | $43 |
Products named: KRYSTEXXA, Bimzelx, RINVOQ, TREMFYA, KEVZARA, OTEZLA, COSENTYX, SKYRIZI.
Industry payments across MI — which companies pay providers there.
